We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

MAR 27 2017

What’s Next for Pharma in the Age of Trump? – The National Law Journal

William Garvin and Alexandre Gapihan, Shareholder and Associate in FDA & Biotechnology, wrote about how the pharmaceutical industry will operate in the age of Trump. Read "What’s Next for Pharma in the Age of Trump?" in The National Law Journal.